Anoat Therapeutics

Anoat Therapeutics is a preclinical-stage company focused on developing new therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Leveraging its strong track record in rare diseases and antisense oligonucleotide (ASO) drug development, the company has built a new pipeline of drug candidates.